Login to Your Account

FDA Publishes Long-Awaited Guidance On Pharmacogenomics

By Aaron Lorenzo

Thursday, March 24, 2005
WASHINGTON - At last, the FDA this week issued guidelines to the drug industry on pharmacogenomics, providing a framework for data submissions to supplement marketing applications and regulatory review, while also outlining a new mechanism for the voluntary submission of research data. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription